Cargando…
10.6-μm infrared laser as adjuvant therapy for diabetic peripheral neuropathy: study protocol for a double-blind, randomized controlled trial
BACKGROUND: Diabetic peripheral neuropathy (DPN) is the most common chronic neurological complication. It is the main cause of disability in diabetes mellitus (DM) patients and seriously affects the quality of life of patients. Pharmacological treatments always associate with limited efficacy and ad...
Autores principales: | Lin, Lin, Chen, Yi, Li, Yuxia, Cheng, Ke, Deng, Haiping, Lu, Jianping, Zhao, Ling, Shen, Xueyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764791/ https://www.ncbi.nlm.nih.gov/pubmed/35042552 http://dx.doi.org/10.1186/s13063-021-05901-6 |
Ejemplares similares
-
Effect of 10.6 μm laser moxibustion on inflammation in diabetic peripheral neuropathy rats
por: Yin, Yue, et al.
Publicado: (2023) -
Comparison of the effects of 10.6-μm infrared laser and traditional moxibustion in the treatment of knee osteoarthritis
por: Lin, Lin, et al.
Publicado: (2019) -
Effect of 10.6-μm CO(2) laser moxibustion on the fastest 15-m walking time in patients with knee osteoarthritis: a double-blind, sham-controlled, multi-site randomized trial
por: Chen, Lusheng, et al.
Publicado: (2023) -
Effects of infrared laser moxibustion on cancer‐related fatigue: A randomized, double‐blind, placebo‐controlled trial
por: Mao, Huijuan, et al.
Publicado: (2016) -
Near-Infrared Laser Adjuvant for Influenza Vaccine
por: Kashiwagi, Satoshi, et al.
Publicado: (2013)